Please assess the completion status of the following clinical trial:

Trial Title: To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 and \< 75~* Cirrhotics with UGIE (Upper Gastrointestinal Endoscopy ) within last 24 hours.~Exclusion Criteria:~* Non cirrhotic~* Hepatocellular carcinoma~* Advanced cardiopulmonary disease~* Pregnancy~* Extrahepatic malignancy~* Patient on anticoagulation therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Standard Care + NAC (N-ACETYLCYSTEINE) infusion (Type: EXPERIMENTAL): None
- Standard Care (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).